Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Eidos Therapeutics
eidos therapeutics, a subsidiary of bridgebio pharma, is developing ag10 as a targeted therapeutic for transthyretin amyloidosis. the company’s singular mission is to improve and prolong the lives of patients suffering from this disease. launched in 2016 after years of research supported by stanford’s spark program, eidos is led by a team of veteran biotechnology executives. together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.
Frequently asked questions about Eidos Therapeutics
Let us help answer the most common questions you might have.
Where is Eidos Therapeutics located?
Eidos Therapeutics' headquarters is located at 101 Montgomery Street, San Francisco, California, United States
What is Eidos Therapeutics' official website?
Eidos Therapeutics' official website is eidostx.com
How many employees does Eidos Therapeutics have?
Eidos Therapeutics has 54 employees
What industry does Eidos Therapeutics belong to?
Eidos Therapeutics is in the industry of: Biotechnology
What are Eidos Therapeutics' social media links?
Eidos Therapeutics Linkedin page
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
